ICONIQ Capital’s Post

🏥 Medikabazaar Appoints Former Healthium MedTech Executive as CEO. Medikabazaar has announced the appointment of a former Healthium MedTech executive as its new CEO, marking a significant leadership transition for the company. 👤 New Leadership: - Medikabazaar has hired a seasoned executive from Healthium MedTech to lead its operations as the new CEO. - The new CEO brings extensive experience in the MedTech industry, which is expected to drive strategic growth and innovation at Medikabazaar. 🚀 Strategic Goals: - The appointment aims to strengthen Medikabazaar's leadership and accelerate its growth trajectory in the medical supplies and healthcare sector. - The new CEO will focus on enhancing the company’s market position, expanding its product offerings, and improving operational efficiency. 🌟 Industry Impact: - The executive’s background in MedTech is expected to bring valuable insights and strategic direction to Medikabazaar. - The move is seen as a step towards bolstering the company’s capabilities and addressing the evolving needs of the healthcare market. 📈 Future Prospects: - Under the new leadership, Medikabazaar is set to pursue ambitious growth plans and enhance its role in the healthcare supply chain. - The leadership change is anticipated to drive innovation and strengthen the company’s competitive edge. Medikabazaar’s appointment of a former Healthium MedTech executive as CEO signifies a strategic move to advance its position in the healthcare industry and pursue new growth opportunities. #Medikabazaar #HealthcareLeadership #MedTech #ExecutiveAppointment #Microshots #StartupNews #NewsUpdates

🌟 We are delighted to announce that our portfolio company, 4D Lifetec, was a standout participant at the SACHS ASSOCIATES 5th Annual European HealthTech CEO Forum for Partnering and Investment held on February 27, 2024. 4D Lifetec’s CEO, Dr. Giancarlo Rizzoli, represented the company as a distinguished panelist on the captivating topic, "New Frontiers in Personalized Medicine with AI Powered Diagnostics." During this dynamic forum, industry leaders engaged in pivotal discussions centered around the revolutionary convergence of AI-powered diagnostics and personalized medicine. Key topics included advancements in treatment detection, leveraging AI for treatment personalization, and navigating the complex landscape of technology and regulatory frameworks. Stay tuned as anfass Life Technologies and 4D Lifetec continue to be among the leaders in transforming diagnostics through innovation and strategic partnerships. https://lnkd.in/djHibSrn   #anfassLifeTechnologies #4DLifetec #HealthTech #PersonalizedMedicine #AI #Innovation #HealthcareRevolution #SACHSAssociates #CEOForum #Investment #Partnership #TechInHealthcare #Leadership #FutureOfHealthcare

In honor of 25th anniversary of partnership between Medtronic PLC and Mediana, the Acute Care & Monitoring OU (ACM) leadership team of Medtronic and Mediana management team celebrated their 25-year in Medtronic Boulder campus on October 1. The beginning of partnership in 1999 was small, but accomplishment is great and will be greater. The partnership of Medtronic and Mediana has been invincible even during global financial crisis in 2008, COVID-19 pandemic and following global supply chain crunch. A quarter century partnership with Medtronic is a great milestone for Mediana to encourage its self-motivated innovation under the new CEO, Eddie Kwak who has run Selvas AI Inc since 1999. Entering new Chapter of partnership, Medtronic and Mediana share strategic goal to contribute to global human welfare incorporating their cutting-edge biomedical technologies. Selvas AI – Mediana merger is expected to accelerate rapid implementation of deep-learning based AI recognition, medical diagnosis and disease prediction to its medical device products. https://lnkd.in/gN6b45vJ https://lnkd.in/gfT7PvaG https://lnkd.in/gC85-9ur

panel discussion on building a resilient quality ecosystem !

🌐 Sad News to Start the Working Week for some MedTech professionals - Hologic, Inc. is restructuring. Just in: Hologic, Inc. is set to close facilities in Finland and France, impacting 190 experts in our field. As a headhunter specialising in MedTech and HealthTech, the news strikes a chord within our community. 💡 Opportunity amid change: For those affected, this could be a pivot point for new ventures and innovations. For decision-makers, it’s a reminder of the industry's dynamism and the importance of agility. 🔍 Executive & Senior tech talent, this is where foresight meets action. If you’re navigating the waters of change, let’s connect. Together, we'll harness your expertise for the next leap in healthcare technology. #MedTech #HealthTech #CareerTransition

The Emerging MedTech Summit is just TEN days away and the PRIA Healthcare team is looking forward to another impactful LSI event! This year Jeffrey Sirek, and his executive team from #PRIA Healthcare will be representing our tenured organization. 🔹Seasoned Industry Expertise: With a 25-year history in healthcare, Jeffrey has deep leadership expertise across multiple business segments: commercial operations, product development, product design, engineering, manufacturing, distribution, and market access. 🔹Building Partnerships: He has extensive experience collaborating with the investment community, including leadership positions with publicly traded and private equity-supported startups. Jeff’s background spans pharma, medical devices, SaaS, AI, and digital health; navigating both the product and service sides of the #MedTech and #LifeScience ecosystem.   🔹Patient Focuses: Throughout his tenure, Jeff has remained focused on patient-centered innovation; aiming to break down the obstacles that often hinder advanced treatments. At #PRIA Healthcare, Jeff and his team leverage their deep market access and reimbursement knowledge to help innovators bring new technology successfully to market. Jeffrey Sirek and the #PRIA team look forward to connecting with innovators, strategics, investors, and industry partners. Message us here or reach out on the LSI partnering app to find time to connect. We look forward to seeing you in Dana Point! #lsiusa24 #emergingmedtech #medtechinnovation Tonya Dowd, MPH, Stephanie DeFelice, eMBA, Marie A., Chelsy Peet, Meghan DeChello

🌟 We are thrilled to share that 4D Lifetec was a prominent participant at the SACHS ASSOCIATES 5th Annual European HealthTech CEO Forum for Partnering and Investment held on February 27, 2024. Our esteemed CEO, Dr. Giancarlo Rizzoli, represented us as a distinguished panelist on the engaging topic, "New Frontiers in Personalized Medicine with AI Powered Diagnostics". During this insightful forum, industry leaders delved into crucial discussions surrounding the revolutionary intersection of AI-powered diagnostics and personalized medicine. Key topics included treatment detection advancements, leveraging AI for treatment personalization, and navigating the intricate landscape of technology and regulatory frameworks. Dr. Giancarlo Rizzoli highlighted 4D Lifetec's pioneering initiatives and innovative solutions. His expertise and visionary insights highlighted our commitment to driving progress in diagnostics through cutting-edge technology and strategic collaborations.  https://lnkd.in/dUbY_MxA #4DLifetec #HealthTech #PersonalizedMedicine #AI #Innovation #HealthcareRevolution #SACHSAssociates #CEOForum #Investment #Partnership #TechInHealthcare #Leadership #FutureOfHealthcare

Qure.ai Secures $65M Series D Funding to Drive Global Healthcare Innovation Qure.ai, a global leader in #healthcareAI, has successfully raised $65 million in a Series D funding round. The company plans to use this new investment to accelerate its growth in the US and other international markets, strengthen its AI capabilities, and explore potential acquisitions of complementary med-tech companies. Headquartered in Mumbai, with offices in New York, London, and Dubai, Qure.ai attracted new investors, including Lightspeed and 360 ONE Asset, with additional backing from Merck Global Health #InnovationFund and Kae Capital. Existing supporters, like Novo Holdings, Health Quad, and TeamFund, also joined the round. Founded in 2016 by Prashant Warier, Qure.ai is on a mission to make healthcare more accessible and equitable worldwide. Its AI solutions, now deployed in over 90 countries across more than 3,000 sites, are designed to identify and manage critical diseases efficiently. The company boasts 18 FDA-cleared indications, and its products meet EU Class IIb #medicaldevice standards. "Qure.ai has become a trusted partner for hospitals and healthcare organizations around the world. Our AI technology is enhancing clinical efficiency and improving patient care, particularly in key areas like tuberculosis, lung cancer, and stroke," said Warier, who also serves as the company’s CEO. He further emphasized the role of AI in tackling global healthcare challenges such as reporting backlogs, low screening rates, and resource shortages. "Our solutions are helping both developed and developing countries, and we’re proud to work with leading Pharma and MedTech companies, including AstraZeneca, Medtronic, and J&J, to ensure early disease diagnosis and timely treatment." https://lnkd.in/fzpnPPW #aihealthcare #qureai #healthtech #medtech #healthcareinnovation #digitalhealth #healthcareai #medtech #globalhealth #clinicalefficiency #techforgood #aiinnovation #healthtechindustry #healthcareinvestment #medtechinnovation #globalhealthtech #medicalai #HealthcareInvestments Qure.ai

As I look back on the first year of my entrepreneurial venture at Genesys Pharmaceuticals, I feel compelled to share some key moments, lessons and milestones that have shaped this new journey that I embarked on, and look forward to see how it continues to unfold: - The strength of the #partnership we have in place with Holmed Group, which is built on a shared purpose: making #healthcare solutions and quality care accessible to patients across the #MEA region. Collaborating with sister companies and talented colleagues at Holmed Group toward this noble goal brings the impossible within reach. Several exciting pipeline projects are approaching execution, offering limitless prospects. - The importance of having an extensive #network spanning multiple geographies, encompassing the entire healthcare value chain, and keeping #patients at its core. This has enabled us to connect research-driven global biopharma and medical device companies with local distributors, health authorities, and medical communities, all driven by a common goal, to best serve the patients and people of our region. - The beauty in the #diversity and complexity of the markets in our region, which opens up a myriad of #opportunities and possibilities for our budding alliances and partnerships. While mindful of market volatility and associated risks, we remain committed to investing, expanding, and establishing our presence across multiple markets; we remain determined to contribute to ongoing healthcare reforms and the region’s evolving healthcare landscape. - The cultural mosaic and intricacies of the countries and people we aim to serve, offering an unlimited source of talent, fueled by a younger generation determined to create change and spur progress, harnessing the power of #technology and #data, driven by their relentless pursuit of a better life. I will sign off with the words of a poet and philosopher from my country, Gibran Khalil Gibran: “Trust in dreams, for in them is hidden the gate to eternity.” Special thanks to Andre Fadel, Randa Aoun, Roy Chartouny, Wael Chourbaji, Rita Slim and Carla Khoury for their continuous support and valuable contributions

We’re delighted to be named the winner of Catalyst for Change Awards in the Visionary Leadership Category for MedTech & Hospital presented by Health Industry Hub! This recognition honors leaders and professionals who have inspired and driven progress across healthcare sectors, including pharma, medtech, diagnostics, and biotech. Liz Carnabuci, VP, Enterprise Accounts & Services, Japan and ANZ; VP, Diabetes APAC and Greater China at Medtronic, spoke with Health Industry Hub’s editor Rozalina Sarkezians. Their conversation, one of the most viewed vodcasts, focused on how AI and digital health are poised to revolutionise healthcare by bringing us closer to personalised care, improved diagnostics, and more efficient systems. Liz highlighted the importance of addressing interoperability challenges, privacy concerns, and stressed the need for a harmonised regulatory approach that supports innovation while ensuring efficacy and safety. We’re proud to be at the forefront of this transformation, working towards a future where digital health and AI improve outcomes for patients we serve! #HealthIndustryHub #EngineeringTheExtraordinary